|
Webinar - Investigation of Surrogate Imaging Markers for Early Diagnosis and Risk Stratification in Parkinson’s Disease
|
|
14
|
112
|
February 18, 2026
|
|
Cross-Modal Harmonization: Can We Standardize Imaging Signatures Across Centers?
|
|
2
|
51
|
November 2, 2025
|
|
Webinar - A Phenoclustering Analysis of PPMI Data for PD Subtyping
|
|
16
|
218
|
July 18, 2025
|
|
AD/PD 2025 - FNIH session
|
|
1
|
41
|
April 23, 2025
|
|
Highlights from AD/PD 2025
|
|
0
|
160
|
April 10, 2025
|
|
Screening for neurodegenerative disease pathologies in pre-symptomatic stages of disease
|
|
5
|
82
|
March 28, 2025
|
|
Current Knowledge on Imaging Markers of Parkinson’s Disease
|
|
1
|
78
|
October 20, 2024
|
|
If you need study design, epidemiology, metabolomics insights
|
|
7
|
91
|
April 15, 2024
|
|
AMP-PD Target Explorer with New Lists!
|
|
3
|
42
|
April 11, 2024
|
|
Navigating PDBP studies
|
|
3
|
85
|
February 9, 2024
|
|
Plasma Biomarkers in Fox Insight
|
|
12
|
144
|
November 14, 2023
|
|
Digital Biomarkers of Parkinson’s Disease
|
|
0
|
50
|
November 8, 2023
|
|
How to obtain transcriptomics data from the PDBP?
|
|
2
|
66
|
October 23, 2023
|